Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest THE ROTTENSTEIN LAW GROUP Stories

2012-01-18 18:45:00

The Rottenstein Law Group, which represents clients with claims stemming from the birth defects caused by the antidepressant Zoloft, has learned of a new study confirming the possibility of a link between mothers who take selective serotonin reuptake inhibitors (SSRIs) including Zoloft and infants born with persistent pulmonary hypertension (PPHN). New York, NY (PRWEB) January 18, 2012 According to a Jan. 12 article on Yahoo! News, a new Swedish study shows that expectant mothers who take...

2012-01-17 10:00:00

The Rottenstein Law Group, which represents clients with claims stemming from the harmful adverse effects of vaginal mesh, is encouraged by the U.S. Food and Drug Administration's Jan. 4 announcement that it is requiring 31 manufacturers of vaginal mesh products to conduct three-year studies of those products' safety and effectiveness. New York, NY (PRWEB) January 17, 2012 The FDA issued the mandate in the form of letters to each of the companies, according to a Jan. 10 Bloomberg...

2012-01-17 10:00:00

The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, takes some comfort in learning that researchers might have found a way to make all-metal hips less dangerous to recipients. New York, NY (PRWEB) January 17, 2012 According to a piece recently published by Reuters, “a substance that forms in patients with all-metal artificial hips turns out to...

2011-12-20 04:15:00

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is repeating the warning given by the AARP that coffee might block the absorption or increase the effects of some medications. New York, NY (PRWEB) December 19, 2011 According to a piece posted at the website of AARP on December 5, âœthe coffee you drink in the morning with some of your prescription drugs can either block their absorption or...

2011-12-08 23:35:00

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has learned that claims in the Fosamax femur fracture multidistrict litigation have been dismissed as against some generic manufacturers of the product. New York, NY (PRWEB) December 08, 2011 As the representative of claimants who allegedly suffered harm as a result of having taken Fosamax or its generic equivalent, the attorneys at the Rottenstein Law Group lament this...

2011-12-08 08:00:00

The Rottenstein Law Group, which represents clients with claims stemming from the recall of defective hip replacement devices manufactured and sold by DePuy Orthopaedics, has read with interest the latest order of the DePuy MDL court. New York, NY (PRWEB) December 08, 2011 By order dated November 28, 2011, Judge David Katz of the United States District Court for the Northern District of Ohio approved an arrangement âœto provide for the fair and equitable sharing...

2011-11-21 16:05:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes with some regret a report that a âœnovel treatment known as whole-body vibration doesnât appear to improve the bone health of postmenopausal women who are at high risk of developing osteoporosis.â New York, NY (PRWEB) November 21, 2011 According to a November 15 piece published by U.S. News and World Report, the treatment,...

2011-11-07 10:00:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, is concerned that many with osteoporosis might not know it and therefore might not be getting necessary treatment timely, but maintains that those who are diagnosed with the condition should discuss with their physicians in detail the possible serious adverse side effects of bisphosphonate drugs. New York, NY (PRWEB) November 07, 2011 According to an October 31, 2011, New York...

2011-10-31 09:00:00

The Rottenstein Law Group, which represents clients with claims stemming from the recall of defective hip replacement devices manufactured and sold by DePuy Orthopaedics, has learned that the next status conference in the multidistrict litigation has been scheduled for November 22. New York, NY (PRWEB) October 31, 2011 By Order dated October 26, 2011, in the Multidistrict Litigation (MDL) known as In re: DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation (MDL Docket No....

2011-10-17 14:25:00

The Rottenstein Law Group, which represents clients with claims stemming from the recall of defective hip replacement devices manufactured and sold by DePuy Orthopaedics, notes with interest the lawsuit of former gymnast Penny Brown against the company. New York, NY (PRWEB) October 17, 2011 According to an October 6 report from the United Kingdom Press Association, former English gymnast Penny Brownâ”who in 2004 received a DePuy ASR device and then agreed to advertise the...